US Stock MarketDetailed Quotes

CRVS Corvus Pharmaceuticals

Watchlist

9.020
-0.080-0.88%

Close Nov 4 16:00 ET

9.020
0.0000.00%

Post 16:00 ET

564.21MMarket Cap-20976P/E (TTM)

Corvus Pharmaceuticals Stock Forum

Bigmoney Dreamer

Oct 30 15:35

$Corvus Pharmaceuticals (CRVS.US)$

Bigmoney Dreamer

Oct 30 15:35

$Corvus Pharmaceuticals (CRVS.US)$

Bigmoney Dreamer

Oct 29 15:47

$Corvus Pharmaceuticals (CRVS.US)$ 👀 📖
Corvus Pharmaceuticals Inc. carries a moderately high risk level, given its mixed fundamentals and recent volatility. Although positive analyst sentiment and a key drug catalyst suggest potential upward movement, the company's financials signal instability with negative earnings and high cash burn. The stock’s position below its 52-week high with an ongoing sector underperformance adds to the unpredictability. Moreover, the biotechnology sector can present ...

Jsmooth420365

Oct 29 12:13

$SKK Holdings (SKK.US)$ $Corvus Pharmaceuticals (CRVS.US)$ are my main 2 as of now

Jsmooth420365

Oct 28 16:28

$Corvus Pharmaceuticals (CRVS.US)$ in with a small swing.. keeping my sl tight on this one.

Bigmoney Dreamer

Oct 28 07:29

$Corvus Pharmaceuticals (CRVS.US)$ 👀already up above key level $ 8.5 looks good but I don’t like pre- market spikes or breakout lets see what open market signals

Bigmoney Dreamer

Oct 25 12:29

$Corvus Pharmaceuticals (CRVS.US)$
The risk associated with trading CRVS stock is moderate due to several contrasting factors. The recent price surge indicates strong market interest and price volatility, posing potential for both significant gains and unexpected reversals. While the upgrade news injects optimism, CRVS's lack of profitability presents a fundamental risk, indicating reliance on external funding rather than internal growth. Additionally, the vibrant trading volume suggests liquidit...